Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Diabesity: The pandemic impacting populations around the globe
Diabesity: Global Epidemic Lede

Diabesity: The pandemic impacting populations around the globe

Obesity and diabetes rates are increasing so much that there’s a term for it: diabesity. Here’s what you should know about this worldwide health crisis.

They’re sobering statistics. Between 1980 and 2013, the number of overweight and obese people grew from 857 million to 2.1 billion globally. Today, over a quarter of those who are obese also have type 2 diabetes.
On their own, obesity and diabetes can lead to serious health complications—but when combined, “diabesity,” as experts are calling the simultaneous rise in both conditions, can really leave a detrimental mark on the health of people in nearly every corner of the globe.

As we mark World Diabetes Day on November 14, see how Johnson & Johnson is lending its support to help with the health crisis—and what steps you can take to be your best, healthy self.

Diabesity: A Global Pandemic Infographic-compressed.jpg

Here’s how you can learn more about the growing impact of diabetes and obesity around the world.

More from Johnson & Johnson

3 nurse practitioners who are filling critical gaps in healthcare

From using cutting-edge technology to address mental health issues to launching an urban clinic that helps treat substance-abuse disorders and taking an innovative approach to deliver rural medical care, learn how Johnson & Johnson is helping support a new generation of providers.

What is a gene mutation?

Experts aren’t sure why, but sometimes changes in DNA can trigger cancer to grow and spread. Learn all about gene mutations—and Johnson & Johnson’s work developing new therapies to target these specific types of cancer.

“Reimagining what life with schizophrenia could look like”

Johnson & Johnson’s Leonardo Diaz, M.D., addresses common misconceptions about schizophrenia, the critical importance of preventing relapse and why there’s so much optimism about treatments.